ALNYLAM PHARMACEUTICALS, INC. R&D Expense 2008-2025 | ALNY
Beta
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is ALNYLAM PHARMACEUTICALS, INC.'s current r&d expense?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual r&d expense for 2025 was $1.32B, a 17.19% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. r&d expense for the quarter ending December 31, 2025 was $372.2M.
What was ALNYLAM PHARMACEUTICALS, INC.'s r&d expense in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual r&d expense for 2024 was $1.13B, a 12.13% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s r&d expense in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual r&d expense for 2023 was $1.00B, a 13.75% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year r&d expense CAGR?
ALNYLAM PHARMACEUTICALS, INC. r&d expense grew at a compound annual growth rate (CAGR) of 15.05% from FY2020 to FY2025, going from $654.8M to $1.32B over 5 years.
R&D Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+15.0%
FY2020
$654.8M
→
FY2025
$1.32B
080910111213141516171819202122232425
5 years selected
R&D Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.32B | +17.2% | 10-K |
| FY2024 | $1.13B | +12.1% | 10-K |
| FY2023 | $1.00B | +13.7% | 10-K |
| FY2022 | $883.0M | +11.5% | 10-K |
| FY2021 | $792.2M | +21.0% | 10-K |
| FY2020 | $654.8M | -0.0% | 10-K |
| FY2019 | $655.1M | +29.6% | 10-K |
| FY2018 | $505.4M | +29.4% | 10-K |
| FY2017 | $390.6M | +2.2% | 10-K |
| FY2016 | $382.4M | +38.3% | 10-K |
| FY2015 | $276.5M | +45.3% | 10-K |
| FY2014 | $190.2M | +68.4% | 10-K |
| FY2013 | $113.0M | +30.5% | 10-K |
| FY2012 | $86.6M | -12.8% | 10-K |
| FY2011 | $99.3M | -6.7% | 10-K |
| FY2010 | $106.4M | -2.2% | 10-K |
| FY2009 | $108.7M | +12.2% | 10-K |
| FY2008 | $96.9M | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →